Late influenza vaccination is associated with reduced effectiveness

被引:9
作者
Chodick, Gabriel
Heymann, Andiony D.
Green, Manfred S.
Kokia, Ehud
Shalev, Varda
机构
[1] Maccabi Healthcare Serv, IL-68125 Tel Aviv, Israel
[2] Tel Aviv Univ, Sackler Fac Med, IL-69978 Tel Aviv, Israel
关键词
influenza; vaccine; timing; hospitalization; mortality;
D O I
10.1016/j.ypmed.2006.02.009
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Background. Extensive research has been carried out to quantify the efficacy and immunologic responses to influenza immunization, however, only little was reported on whether the timing of vaccine administration affects its effectiveness. The study aims were to compare post-immunization hospitalization and mortality rates among high-risk patients who were vaccinated against influenza in different periods of autumn. Methods. Data for the current population-based historical prospective study were obtained from a large health organization in Israel insuring 1,600,000 members. Study population (n = 68,166) included high-risk patients aged 55 and above, who were immunized against influenza between October and November 2003. Results. Although at baseline, individuals vaccinated in late November (12-25/11/2003) were significantly younger and had lower burden of illness compared to those vaccinated in early October (1-13/10/2003), they had higher hospitalization rates and longer hospital stay during the following winter (December to March). They also had an increased risk for all-cause mortality (RR = 1.78; 95%CI: 1.13-2.80). No such differences were observed during the following summer (April-August). Conclusions. In countries where influenza generally peaks between December and early March, vaccines administered after mid-November might be less beneficial. (c) 2006 Elsevier Inc. All rights reserved.
引用
收藏
页码:71 / 76
页数:6
相关论文
共 27 条
[1]   Side effects of influenza vaccination in healthy older people: A randomised single-blind placebo-controlled trial [J].
Allsup, SJ ;
Gosney, M ;
Regan, M ;
Haycox, A ;
Fear, S ;
Johnstone, FCW .
GERONTOLOGY, 2001, 47 (06) :311-314
[2]  
CATE TR, 1983, REV INFECT DIS, V5, P737
[3]   The epidemiology of diabetes in a large Israeli HMO [J].
Chodick, G ;
Heymann, AD ;
Shalev, V ;
Kookia, E .
EUROPEAN JOURNAL OF EPIDEMIOLOGY, 2003, 18 (12) :1143-1146
[4]   Comparison between cohorts vaccinated and unvaccinated against influenza and pneumococcal infection [J].
Christenson, B ;
Lundbergh, P .
EPIDEMIOLOGY AND INFECTION, 2002, 129 (03) :515-524
[5]  
COX DR, 1972, J R STAT SOC B, V34, P187
[6]   ADVERSE REACTIONS TO INFLUENZA VACCINE IN ELDERLY PEOPLE - RANDOMIZED DOUBLE-BLIND PLACEBO-CONTROLLED TRIAL [J].
GOVAERT, TME ;
DINANT, GJ ;
ARETZ, K ;
MASUREL, N ;
SPRENGER, MJW ;
KNOTTNERUS, JA .
BMJ-BRITISH MEDICAL JOURNAL, 1993, 307 (6910) :988-990
[7]   Time to earliest peak serum antibody response to influenza vaccine in the elderly [J].
Gross, PA ;
Russo, C ;
Dran, S ;
Cataruozolo, P ;
Munk, G ;
Lancey, SC .
CLINICAL AND DIAGNOSTIC LABORATORY IMMUNOLOGY, 1997, 4 (04) :491-492
[8]   Confounding by indication in non-experimental evaluation of vaccine effectiveness: the example of prevention of influenza complications [J].
Hak, E ;
Verheij, TJM ;
Grobbee, DE ;
Nichol, KL ;
Hoes, AW .
JOURNAL OF EPIDEMIOLOGY AND COMMUNITY HEALTH, 2002, 56 (12) :951-955
[9]   Influence of high-risk medical conditions on the effectiveness of influenza vaccination among elderly members of 3 large managed-care organizations [J].
Hak, E ;
Nordin, J ;
Wei, FF ;
Mullooly, J ;
Poblete, S ;
Strikas, R ;
Nichol, KL .
CLINICAL INFECTIOUS DISEASES, 2002, 35 (04) :370-377
[10]   Effects of a large-scale intervention with influenza and 23-valent pneumococcal vaccines in elderly people:: a 1-year follow-up [J].
Hedlund, J ;
Christenson, B ;
Lundbergh, P ;
Örtqvist, Å .
VACCINE, 2003, 21 (25-26) :3906-3911